OncoSec Medical


OncoSec Prices $15M Offering; Analyst Sees Further 150% Upside Ahead

Late-stage biotech OncoSec Medical (ONCS) has announced that it has entered into purchase agreements for an aggregate 4,608,589 of its shares at an offering …

Why OncoSec Medical (ONCS) Stock Crashed Today

Some investors might love biotech stocks for their lottery ticket-like returns when a company strikes medical gold. A lottery ticket, however, costs only …

H.C. Wainwright Upbeat on OncoSec Medical Following Updated Phase 2 Data

OncoSec Medical (NASDAQ:ONCS) just hit clinical trial results out of the park in the melanoma arena, with a Phase 2 combination trial that …

H.C. Wainwright Maintains Buy On OncoSec Following FY1Q15 Update

In a research report sent to investors today, H.C.

H.C. Wainwright Reiterates Buy On OncoSec Following FY4Q14 Results

In a research report published today, H.C.

We See A Year Of Growth And Transition Ahead At OncoSec, Says Maxim Group

In a research note released today, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on OncoSec Medical (OTC:ONCS) with a $3 price …

H.C. Wainwright Reiterates Buy On OncoSec Following YTD Results

In a research note issued this morning, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts